JPMorgan says own this drug stock. It's one Jim Cramer is itching to buy again

Mar 15, 2025 - 02:00

JPMorgan says own this drug stock. It's one Jim Cramer is itching to buy again

The Club remains optimistic about Bristol Myers and shares JPMorgan's enthusiasm about Cobenfy.

Related Posts

Canes re-sign Robinson to 4-year, $6.8M deal

Canes re-sign Robinson to 4-year, $6.8M deal

Jun 20, 2025

Stars ink D Lundkvist, F Bourque to 1-year deals

Stars ink D Lundkvist, F Bourque to 1-year deals

Jun 20, 2025

Ex-Blackhawk Toews signing with hometown Jets

Ex-Blackhawk Toews signing with hometown Jets

Jun 20, 2025

Blackhawks re-sign Donato to 4-year, $16M deal

Blackhawks re-sign Donato to 4-year, $16M deal

Jun 20, 2025

Grading the Flyers, Ducks on the Trevor Zegras trade

Grading the Flyers, Ducks on the Trevor Zegras trade

Jun 23, 2025

NHL draft buzz: How Blackhawks, Isles, Predators could shake up first round

NHL draft buzz: How Blackhawks, Isles, Predators could ...

Jun 23, 2025